Sofgen Pharma S.A. (PROCF)

Sofgen Pharma Revenue

In the year 2024, Sofgen Pharma had annual revenue of $373.80M, down -11.79%. Sofgen Pharma had revenue of $118.41M in the quarter ending September 30, 2023, with 7.25% growth. That makes Sofgen Pharma the 13,052nd largest company in the world by revenue and 2,473rd in the United States.

• Revenue: 373.80M
• Revenue Growth: -8.48%
• P/S Ratio: 0.08
• Revenue / Employee: 83.10K
• Employees: 4,498
• Market Cap: 30.03M

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Nextgel 221.71M 41.8%
• Procaps Colombia 139.52M 26.3%
• CASAND 65.91M 12.4%
• CAN 58.56M 11.0%
• Diabetrics 44.57M 8.4%

By Geography

Chart

• South America 256.76M 68.7%
• Central America 57.88M 15.5%
• North America 49.85M 13.3%
• Europe 9.31M 2.5%

Fiscal year ended Dec 31, 2024 See the full Sofgen Pharma breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	373.80M	-49.95M	-11.79%
Dec 31, 2023	423.75M	20.55M	5.10%
Dec 31, 2022	403.20M	-536.00K	-0.13%
Jan 1, 2022	403.74M	72.27M	21.80%
Dec 31, 2020	331.47M	6.68M	2.06%

Data Source: S&P Global Market Intelligence Last updated: Dec 26, 2023

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 5, 2026

Data Sources Report a data error